2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working PartyMichael Heuser, Jacqueline Cloos, Barbara Denys et al.|Blood|2021Cited by 714
Daratumumab for eradication of minimal residual disease in high-risk advanced relapse of T-cell/CD19/CD22-negative acute lymphoblastic leukemiaYishai Ofran, Avraham Frisch, Shimrit Ringelstein‐Harlev et al.|Leukemia|2019Cited by 69
Adult Nephrotic Syndrome after Hematopoietic Stem Cell Transplantation: Renal Pathology is the Best Predictor of Response to TherapyOfrat Beyar‐Katz, Yishai Ofran, Etty Kruzel Davila et al.|Biology of Blood and Marrow Transplantation|2015Cited by 50
2025 update on MRD in acute myeloid leukemia: a consensus document from the ELN-DAVID MRD Working PartyJacqueline Cloos, Michael Heuser, Peter J.M. Valk et al.|Blood|2025Cited by 22
Anti-herpesvirus prophylaxis, pre-emptive treatment or no treatment in adults undergoing allogeneic transplant for haematological disease: systematic review and meta-analysisOfrat Beyar‐Katz, M. Paul, Roni Bitterman et al.|Clinical Microbiology and Infection|2019Cited by 14